trustmebro.to/r/…
✓ checked
trust me, bro:
here is the receipt.
the claim

Patients develop pharmacological tolerance or immunity to psychiatric drugs

the verdict
SUPPORTED
the evidence backs this
Recorded sources
3 sources for · 0 against

Counts group repeated records of the same source within each side. They do not measure evidence strength or source independence.

Is it true that patients develop pharmacological tolerance or immunity to psychiatric drugs?

Yes. Clinical literature confirms that patients can develop pharmacological tolerance, often termed tachyphylaxis, during long-term treatment with psychiatric medications such as antidepressants, leading to a reduced therapeutic response over time.

Verdict: SUPPORTED · 3 sources for, 0 against · Last checked

The analysis

The claim states that patients develop pharmacological tolerance or immunity to psychiatric drugs. Papers [1], [4], and [11] explicitly discuss antidepressant tolerance and tachyphylaxis, where patients lose initial response and experience symptom relapse despite ongoing treatment. No retrieved papers refute the existence of tolerance or tachyphylaxis in psychiatric medications. Therefore, the balance verdict is SUPPORTED.

Evidence for · 3
Tachyphylaxis in major depressive disorder: A review of the current state of research.
2019
The review examines antidepressant tachyphylaxis, where patients experience re-emergence or worsening of symptoms despite ongoing treatment with previously effective pharmacotherapy.
Get citation
Kinrys, G., Gold, A. K., Pisano, V. D., Freeman, M., Papakostas, G., Mischoulon, D., Nierenberg, A., & Fava, M. (2019). Tachyphylaxis in major depressive disorder: A review of the current state of research.. doi.org. https://doi.org/10.1016/j.jad.2018.10.357

See more details
More for · 2
Recommendations for the Deprescribing of Psychotropic Medications: A Consensus Statement From the American Society of Clinical Psychopharmacology Task Force.
2026
The consensus statement identifies drug tolerance or tachyphylaxis as a key factor in clinical psychopharmacology and deprescribing decisions.
Get citation
Goldberg, J. F., McIntyre, R. S., Swartz, H., Freeman, M. P., Mago, R., Citrome, L., Rosenblat, J., Thase, M. E., Tohen, M., Vieta, E., Malhi, G. S., Sajatovic, M., Shelton, R. C., Macaluso, M., Berk, M., Perlis, R. H., Ostacher, M., Khan, A., Iosifescu, D., Sanacora, G., Rubio, J., Kane, J. M., Goodman, D. W., Nierenberg, A., Correll, C., Kupka, R., Kasper, S., Furukawa, T. A., Davis, L. L., Aaronson, S. T., Gitlin, M., Jha, M. K., Cohen, L., Papakostas, G., Mitchell, P. B., Gorwood, P., Gupta, S., Frye, M. A., Young, A., Zohar, J., Steingard, S., Zarate, C. A., & Clayton, A. (2026). Recommendations for the Deprescribing of Psychotropic Medications: A Consensus Statement From the American Society of Clinical Psychopharmacology Task Force.. doi.org. https://doi.org/10.1001/jamanetworkopen.2026.0043

Esmethadone (REL-1017) in Patients With Major Depressive Disorder and Antidepressant Tachyphylaxis: An Exploratory Post Hoc Analysis From a Phase 3 Randomized Controlled Trial.
2025
The exploratory analysis specifically investigates and confirms treatment responses in patients with major depressive disorder who developed antidepressant tolerance or tachyphylaxis.
Get citation
Guidetti, C., Papakostas, G., Pani, L., Martin, S. D., Serra, G., Apicella, M., Kröger, C., Champasa, P., Comai, S., Mattarei, A., Folli, F., Pappagallo, M., Manfredi, P. L., & Fava, M. (2025). Esmethadone (REL-1017) in Patients With Major Depressive Disorder and Antidepressant Tachyphylaxis: An Exploratory Post Hoc Analysis From a Phase 3 Randomized Controlled Trial.. doi.org. https://doi.org/10.4088/jcp.24m15748

Receipt History
first checked04 Aug 2026
judged → SUPPORTED · 8504 Aug 2026
Anyone with this link can read the claim and its public receipt, including any personal information in that text. Open permanent receipt.
Check your own claim
Challenge the receipt
Requests are recorded for review. This does not start an automatic check or guarantee a response time.

See the evidence timeline

Citation formatting by citeproc-js (Frank Bennett) and the Citation Style Language project. Source and licenses.

This receipt is an automated verdict against our published method · not an opinion about any author or publication.
Terms · Privacy · How verdicts work